메뉴 건너뛰기




Volumn 25, Issue 5, 2004, Pages 238-241

The inflow and outflow of anti-glaucoma drugs

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIGLAUCOMA AGENT; APRACLONIDINE; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETAXOLOL; BIMATOPROST; BRIMONIDINE; BRINZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; CLONIDINE; DORZOLAMIDE; FLUPROSTENOL; ISOPRENALINE; LATANOPROST; MUSCARINIC AGENT; PILOCARPINE; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROSTANOID; SALBUTAMOL; TIMOLOL; TRAVOPROST; UNINDEXED DRUG; UNOPROSTONE ISOPROPYL ESTER;

EID: 2142753015     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2004.03.002     Document Type: Short Survey
Times cited : (35)

References (33)
  • 1
    • 0013866340 scopus 로고
    • Conventional and uveoscleral drainage of aqueous humor in the cynomolgus monkey (Macaca irus) at normal and high intraocular pressures
    • Bill A. Conventional and uveoscleral drainage of aqueous humor in the cynomolgus monkey (Macaca irus) at normal and high intraocular pressures. Exp. Eye Res. 51:1966;45-54
    • (1966) Exp. Eye Res. , vol.51 , pp. 45-54
    • Bill, A.1
  • 2
    • 0242500296 scopus 로고    scopus 로고
    • Aqueous humor dynamics and trabecular meshwork and anterior ciliary muscle morphological changes with age in Rhesus monkeys
    • Gabelt B.T., et al. Aqueous humor dynamics and trabecular meshwork and anterior ciliary muscle morphological changes with age in Rhesus monkeys. Invest. Ophthalmol. Vis. Sci. 44:2003;2118-2125
    • (2003) Invest. Ophthalmol. Vis. Sci. , vol.44 , pp. 2118-2125
    • Gabelt, B.T.1
  • 3
    • 0014707894 scopus 로고
    • Effects of topically applied isoproterenol on aqueous humor dynamics in man
    • Ross R.A., Drance S.M. Effects of topically applied isoproterenol on aqueous humor dynamics in man. Arch. Ophthalmol. 83:1970;39-46
    • (1970) Arch. Ophthalmol. , vol.83 , pp. 39-46
    • Ross, R.A.1    Drance, S.M.2
  • 4
    • 0016293766 scopus 로고
    • β-adrenergic responses in the eyes of rabbits, primates and man
    • Langham M.E., Diggs E. β-adrenergic responses in the eyes of rabbits, primates and man. Exp. Eye Res. 19:1974;281-295
    • (1974) Exp. Eye Res. , vol.19 , pp. 281-295
    • Langham, M.E.1    Diggs, E.2
  • 6
    • 0033044222 scopus 로고    scopus 로고
    • Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients
    • Toris C.B., et al. Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients. Am. J. Ophthalmol. 128:1999;8-14
    • (1999) Am. J. Ophthalmol. , vol.128 , pp. 8-14
    • Toris, C.B.1
  • 7
    • 0034754201 scopus 로고    scopus 로고
    • Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension
    • Woldemussie E., et al. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest. Ophthalmol. Vis. Sci. 42:2001;2849-2855
    • (2001) Invest. Ophthalmol. Vis. Sci. , vol.42 , pp. 2849-2855
    • Woldemussie, E.1
  • 8
    • 0017605449 scopus 로고
    • Timolol: Dose response and duration of action
    • Zimmerman T.J., Kaufman H.E. Timolol: dose response and duration of action. Arch. Ophthalmol. 95:1977;605-607
    • (1977) Arch. Ophthalmol. , vol.95 , pp. 605-607
    • Zimmerman, T.J.1    Kaufman, H.E.2
  • 9
    • 0020026359 scopus 로고
    • A new β-adrenergic blocking agent for treatment of glaucoma
    • Berriospi A.R., Leibowitz H.M. A new β-adrenergic blocking agent for treatment of glaucoma. Arch. Ophthalmol. 100:1982;943-946
    • (1982) Arch. Ophthalmol. , vol.100 , pp. 943-946
    • Berriospi, A.R.1    Leibowitz, H.M.2
  • 10
    • 0028863609 scopus 로고
    • A double-masked, randomized 1-year study comparing Dorzolamide (Trusopt), Timolol and Betaxolol
    • Strahlman E., et al. A double-masked, randomized 1-year study comparing Dorzolamide (Trusopt), Timolol and Betaxolol. Arch. Ophthalmol. 113:1995;1009-1016
    • (1995) Arch. Ophthalmol. , vol.113 , pp. 1009-1016
    • Strahlman, E.1
  • 11
    • 0025022342 scopus 로고
    • Chemical and pharmacological properties of MK927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical route
    • Maren T.H., et al. Chemical and pharmacological properties of MK927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical route. Exp. Eye Res. 50:1990;27-36
    • (1990) Exp. Eye Res. , vol.50 , pp. 27-36
    • Maren, T.H.1
  • 12
    • 0030030798 scopus 로고    scopus 로고
    • Trusopt, a topical carbonic anhydrase inhibitor
    • Donohue E.K., Wilensky J.T. Trusopt, a topical carbonic anhydrase inhibitor. J. Glaucoma. 5:1996;68-74
    • (1996) J. Glaucoma , vol.5 , pp. 68-74
    • Donohue, E.K.1    Wilensky, J.T.2
  • 14
    • 0033047027 scopus 로고    scopus 로고
    • 2α metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension
    • 2α metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension. Curr. Med. Res. Opin. 15:1999;87-93
    • (1999) Curr. Med. Res. Opin. , vol.15 , pp. 87-93
    • Nordmann, J.-P.1
  • 15
    • 0034744394 scopus 로고    scopus 로고
    • 2α-isopropyl ester to latanoprost: A review of the development of xalatan
    • 2α-isopropyl ester to latanoprost: a review of the development of xalatan. Invest. Ophthalmol. Vis. Sci. 42:2001;1134-1145
    • (2001) Invest. Ophthalmol. Vis. Sci. , vol.42 , pp. 1134-1145
    • Stjernschantz, J.1
  • 16
    • 0035203853 scopus 로고    scopus 로고
    • Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist
    • Hellberg M.R., et al. Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist. J. Ocul. Pharmacol. Ther. 17:2001;421-432
    • (2001) J. Ocul. Pharmacol. Ther. , vol.17 , pp. 421-432
    • Hellberg, M.R.1
  • 17
    • 0034766578 scopus 로고    scopus 로고
    • The pharmacology of bimatoprost (Lumigan™)
    • Woodward D.F., et al. The pharmacology of bimatoprost (Lumigan™). Surv. Ophthalmol. 45:2001;S337-S345
    • (2001) Surv. Ophthalmol. , vol.45
    • Woodward, D.F.1
  • 18
    • 0141430069 scopus 로고    scopus 로고
    • Morphological changes in the anterior eye segment after long term treatment with different receptor selective prostaglandin agonists and a prostamide
    • Richter M., et al. Morphological changes in the anterior eye segment after long term treatment with different receptor selective prostaglandin agonists and a prostamide. Invest. Ophthalmol. Vis. Sci. 44:2003;4419-4426
    • (2003) Invest. Ophthalmol. Vis. Sci. , vol.44 , pp. 4419-4426
    • Richter, M.1
  • 19
    • 0034910110 scopus 로고    scopus 로고
    • 2α-isopropyl ester treatment
    • 2α-isopropyl ester treatment. Arch. Ophthalmol. 119:2001;1165-1170
    • (2001) Arch. Ophthalmol. , vol.119 , pp. 1165-1170
    • Gaton, D.D.1
  • 20
    • 0036905886 scopus 로고    scopus 로고
    • Latanoprost's effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells
    • Anthony T., et al. Latanoprost's effects on TIMP-1 and TIMP-2 expression in human ciliary muscle cells. Invest. Ophthalmol. Vis. Sci. 43:2002;3705-3711
    • (2002) Invest. Ophthalmol. Vis. Sci. , vol.43 , pp. 3705-3711
    • Anthony, T.1
  • 21
    • 0037697095 scopus 로고    scopus 로고
    • 2 agonist) on Cyr 61 and Connective Tissue Growth Factor gene expression
    • 2 agonist) on Cyr 61 and Connective Tissue Growth Factor gene expression. J. Biol. Chem. 278:2003;27267-27277
    • (2003) J. Biol. Chem. , vol.278 , pp. 27267-27277
    • Liang, Y.1
  • 22
    • 0037370463 scopus 로고    scopus 로고
    • Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost
    • Gandolfi S.A., Cimino L. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost. Ophthalmology. 110:2003;609-614
    • (2003) Ophthalmology , vol.110 , pp. 609-614
    • Gandolfi, S.A.1    Cimino, L.2
  • 23
    • 0037404481 scopus 로고    scopus 로고
    • Pharmacological characterization of a novel anti-glaucoma agent, bimatoprost (AGN 192024)
    • Woodward D.F., et al. Pharmacological characterization of a novel anti-glaucoma agent, bimatoprost (AGN 192024). J. Pharmacol. Exp. Ther. 305:2003;772-785
    • (2003) J. Pharmacol. Exp. Ther. , vol.305 , pp. 772-785
    • Woodward, D.F.1
  • 24
    • 0035824702 scopus 로고    scopus 로고
    • Bimatoprost and its free acid are prostaglandin FP receptor agonists
    • Sharif N.A., et al. Bimatoprost and its free acid are prostaglandin FP receptor agonists. Eur. J. Pharmacol. 432:2001;211-213
    • (2001) Eur. J. Pharmacol. , vol.432 , pp. 211-213
    • Sharif, N.A.1
  • 25
    • 0035957553 scopus 로고    scopus 로고
    • Exploring the potential for subtype-selective muscarinic agonists in glaucoma
    • Gil D.W., et al. Exploring the potential for subtype-selective muscarinic agonists in glaucoma. Life Sci. 68:2001;2601-2604
    • (2001) Life Sci. , vol.68 , pp. 2601-2604
    • Gil, D.W.1
  • 26
    • 0032725983 scopus 로고    scopus 로고
    • Is neuroprotection a viable therapy for glaucoma?
    • Weinreb R.N., Levin L.A. Is neuroprotection a viable therapy for glaucoma? Arch. Ophthalmol. 117:1999;1540-1544
    • (1999) Arch. Ophthalmol. , vol.117 , pp. 1540-1544
    • Weinreb, R.N.1    Levin, L.A.2
  • 27
    • 0035082121 scopus 로고    scopus 로고
    • Various concentrations of topically applied brimonidine tartrate 0.2%
    • Kent A.R., et al. Various concentrations of topically applied brimonidine tartrate 0.2%. Ophthalmology. 108:2001;784-787
    • (2001) Ophthalmology , vol.108 , pp. 784-787
    • Kent, A.R.1
  • 28
    • 0035198185 scopus 로고    scopus 로고
    • Alpha2-adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia
    • Donello J.E., et al. Alpha2-adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia. J. Pharmacol. Exp. Ther. 296:2001;216-223
    • (2001) J. Pharmacol. Exp. Ther. , vol.296 , pp. 216-223
    • Donello, J.E.1
  • 29
    • 0032879302 scopus 로고    scopus 로고
    • Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina
    • Osborne N.N., et al. Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina. Exp. Eye Res. 69:1999;331-342
    • (1999) Exp. Eye Res. , vol.69 , pp. 331-342
    • Osborne, N.N.1
  • 30
    • 0033578378 scopus 로고    scopus 로고
    • Inhibition of nitric oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma
    • Neufeld A.H., et al. Inhibition of nitric oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc. Natl. Acad. Sci. U. S. A. 96:1999;9944-9948
    • (1999) Proc. Natl. Acad. Sci. U. S. A. , vol.96 , pp. 9944-9948
    • Neufeld, A.H.1
  • 31
    • 0036913245 scopus 로고    scopus 로고
    • Neuroprotective effect of memantine in different retinal injury models in rats
    • Woldemussie E., et al. Neuroprotective effect of memantine in different retinal injury models in rats. J. Glaucoma. 11:2002;474-480
    • (2002) J. Glaucoma , vol.11 , pp. 474-480
    • Woldemussie, E.1
  • 32
    • 0019445529 scopus 로고
    • Fluorophotometric study of epinephrine and timolol in human subjects
    • Schenker H.I., et al. Fluorophotometric study of epinephrine and timolol in human subjects. Arch. Ophthalmol. 99:1981;1212-1216
    • (1981) Arch. Ophthalmol. , vol.99 , pp. 1212-1216
    • Schenker, H.I.1
  • 33
    • 0035163062 scopus 로고    scopus 로고
    • Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics
    • Brubaker R.F., et al. Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics. Am. J. Ophthalmol. 131:2001;19-24
    • (2001) Am. J. Ophthalmol. , vol.131 , pp. 19-24
    • Brubaker, R.F.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.